Zacks Investment Research on MSN
COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM
Cogent Biosciences COGT announced that the FDA has accepted the new drug application (“NDA”) seeking approval for its lead pipeline candidate, bezuclastinib, for treating patients with non-advanced ...
Replit Inc., a startup with an artificial intelligence platform that enables users to create websites and mobile apps, has raised $400 million in funding. The company announced the investment on ...
Replit raised $400 million in a new round of fundraising, tripling the software-development platform's valuation to $9 billion. Investors in the round included Georgian, Prysm Capital, YC, Andreessen ...
Shares of Xenon Pharmaceuticals XENE surged 49.6% yesterday after the company announced positive top-line data from the phase III X-TOLE2 study, which evaluated its lead pipeline candidate ...
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
Omaha-based billionaire value investor and former Chief Executive Officer (CEO) of Berkshire Hathaway, who is well known for his long-term investment approach to the stock market, once said that the ...
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Shares of Replimune Group, Inc. (REPL) have gained 0.7% over the past four weeks to close the last trading session at $7.76, but there could still be a solid upside left in the stock if short-term ...
Rent-A-Center rebranded as Upbound in early 2023. More than just a name refresh, Upbound has acquired two interesting tech companies that play into its strengths. The stock's 8.2% yield is well ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Complete PayPal Holdings Inc. stock information by Barron's. View real-time PYPL stock price and news, along with industry-best analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results